Target (CBDY) Net Cash Flow (2013 - 2026)
Target (CBDY) reported Net Cash Flow of $106850.0 for Q1 2026, up 109.72% year-over-year from $50949.3 in Q1 2025, and up 144.81% quarter-over-quarter from -$238448.0 in Q4 2025.
Target (CBDY) Net Cash Flow (2013 - 2026) Analysis & Trends
Target (CBDY) has 14 years of Net Cash Flow data on file, last reported at $106850.0 in Q1 2026.
- Net Cash Flow for Q1 2026 came in at $106850.0, up 109.72% year-over-year; the trailing twelve-month figure through Mar 2026 was -$619530.0 (down 601.36% YoY), and the FY2025 annual result was -$1.8 million, down 245.66% from the prior year.
- Net Cash Flow advanced to $106850.0 in Q1 2026 per CBDY's latest filing, from -$238448.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at $1.0 million in Q2 2024 and troughed at -$1.1 million in Q1 2025.
- A 5-year average of $9905.1 and a median of $23393.0 in 2022 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2023 and 2025: Net Cash Flow jumped 1052.32% in 2023, then plunged 3713.03% in 2025.
- A 5-year view of Net Cash Flow shows it stood at $23393.0 in 2022, then jumped by 1052.32% to $269562.0 in 2023, then jumped by 156.45% to $691285.0 in 2024, then sank by 134.49% to -$238448.0 in 2025, then jumped by 144.81% to $106850.0 in 2026.
- Business Quant data shows CBDY's Net Cash Flow at $106850.0 in Q1 2026, -$238448.0 in Q4 2025, and -$489713.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | 202.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | -526.00 Mn |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | -277.40 Mn |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | -446.50 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | -112.00 Mn |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | -768.22 Mn |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 139.49 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -3.97 Mn |
| 10 | Target | - | - | 191,787.00 | 106,850.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 106,850.00 |
| Mar 31, 2026 | 106,850.00 |
| Dec 31, 2025 | -238,448.00 |
| Dec 31, 2025 | -238,448.00 |
| Sep 30, 2025 | -489,713.00 |
| Sep 30, 2025 | -489,713.00 |
| Jun 30, 2025 | 1,781.00 |
| Jun 30, 2025 | 1,781.00 |
| Mar 31, 2025 | -1.10 Mn |
| Mar 31, 2025 | -1.10 Mn |
| Dec 31, 2024 | 691,285.00 |
| Dec 31, 2024 | 691,285.00 |
| Sep 30, 2024 | -471,036.00 |
| Sep 30, 2024 | -471,036.00 |
| Jun 30, 2024 | 1.00 Mn |
| Jun 30, 2024 | 1.00 Mn |
| Mar 31, 2024 | 30,431.00 |
| Mar 31, 2024 | 30,431.00 |
| Dec 31, 2023 | 269,562.00 |
| Dec 31, 2023 | 269,562.00 |